Prep for gays
Twice-yearly injectable PrEP is highly effective for gay men and trans individuals
PrEP
Twice-yearly lenacapavir reduced the risk of HIV acquisition by 96% among gay and bisexual person men and transgender and nonbinary people.
Twice-yearly injectable pre-exposure prophylaxis (PrEP) has the potential to transform the HIV prevention landscape, but only if it’s widely accessible to everyone who needs it, researchers and advocates say.
At the International AIDS Conference in July, researchers reported that semi-annual injections of Gilead Sciences’ antiretroviral drug lenacapavir were 100% effective for preventing HIV among fresh cisgender women in Africa. Now, a parallel learn has shown that the same regimen reduced the risk of HIV acquisition by 96% among homosexual and bisexual men and transgender and nonbinary people in the United States and six other countries.
Together, these data position lenacapavir PrEP for Food and Drug Administration (FDA) endorsement for HIV prevention, possibly as soon as next year. Gilead is also testing lenacapavir PrEP for cisgender women in the United States and for people who inject drugs.
“The re
Source
Nearly 70% of people living with HIV are lesbian and bisexual men – and thankfully the employ of PrEP for HIV prevention is increasing among this group. According to a recent study, the number of gay and bisexual males taking PrEP increased by 500% from 2014 to 2017. However, only 35% of homosexual and bisexual males who were at high-risk of HIV transmission were taking the medication.
It is key that everyone takes the proper precautions to safeguard themselves from HIV transmission. While some people are at more risk than others due to lifestyle choices or other practices, there is a ordinary misconception that your uncertainty of HIV transmission is higher or lower depending on your sexual orientation or preferred sexual position.
PrEP is designed to support protect any person – regardless of sexual orientation – from HIV transmission. But, you may be wondering if PrEP could affect you differently or be more or less effective depending on if you are a uppermost, bottom, or vers.
For instance, many tops assume they do not need to take PrEP since they are at a bring down risk of contracting HIV than a bottom – since they are not penetrated.
So, does PrEP serve differently
News
The recent decision by the Trump administration to restrict access to life-saving PrEP (pre-exposure prophylaxis) medication for LGBTQ+ people, sex workers, and other high-risk groups through the President’s Emergency Plan for AIDS Relief (PEPFAR) is a horrifying act of cruelty. PrEP is a highly efficient medication that prevents HIV transmission. When taken consistently, PrEP reduces the chance of contracting HIV by up to 99%, making it one of the most important tools in the fight against the global HIV/AIDS epidemic. By limiting PrEP distribution to only pregnant and breastfeeding women in countries receiving U.S. aid, this administration has deliberately abandoned countless vulnerable people to the risk of HIV. This policy is not only medically indefensible but also a moral failure that betrays our shared contact to care for God’s beloved children, especially the marginalized and oppressed.
A Death Sentence for the Most Vulnerable
PEPFAR has been one of the most achieving global health programs in history, saving millions of lives by preventing and treating HIV/AIDS in some of the world’s most vulnerable communities. By cutting off PrEP access to LGBTQ+ people and sex w
In 2012, the fight to end the HIV epidemic changed forever. A novel medication called Pre-Exposure Prophylaxis (PrEP) was approved by the FDA as an efficient medication to prevent sexual transmission. The first shape of PrEP for HIV was Truvada, a prescription medication that showed up to 99% effectiveness at preventing transmission.
Although the drug was approved for use for all genders, it was also heavily marketed toward the LGBTQ community. And when the drug was initially developed, it was primarily studied within groups of men and gender non-conforming women who had sex with men.
However, anyone who is sexually active or who participates in certain behaviors is at chance of HIV transmission. New reports are also showing that now more people who identify as heterosexual are being diagnosed with HIV than gay men for the first time.
There are now multiple forms of PrEP for HIV prevention that have been approved. But is it only harmless for gay, cisgender males to take – or can other genders and people of varying sexual orientations take it as well?
1. Who is At-Risk of HIV Transmission?
First, it is important to understand why PrEP was first primarily prescribed to gay men.
Men w
.